Guillaume Poliquin
Winnipeg, MB, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Improved VSV-Ebola-GP booster vaccination approach promotes antibody affinity maturation and durable anti-Ebola immunity in humans.
Journal: Nature immunology
Published: July 14, 2025
Case Series of Jamestown Canyon Virus Infections with Neurologic Outcomes, Canada, 2011-2016.
Journal: Emerging infectious diseases
Published: April 26, 2024
Safety and immunogenicity of a delayed booster dose of the rVSVΔG-ZEBOV-GP vaccine for prevention of Ebola virus disease: a multicentre, open-label, phase 2 randomised controlled trial.
Journal: The Lancet. Microbe
Published: September 25, 2023
Salivary testing for SARS-CoV-2 in the pediatric population: a diagnostic accuracy study.
Journal: CMAJ open
Published: November 08, 2022
Differential Infectivity of Original and Delta Variants of SARS-CoV-2 in Children Compared to Adults.
Journal: Microbiology spectrum
Published: August 16, 2022
Rapid antigen-based and rapid molecular tests for the detection of SARS-CoV-2: a rapid review with network meta-analysis of diagnostic test accuracy studies.
Journal: BMC medicine
Published: August 12, 2022
Persistence of live virus in critically ill patients infected with SARS-COV-2: a prospective observational study.
Journal: Critical care (London, England)
Published: October 04, 2021
Title Not Found
Journal: CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne
Published: March 30, 2021
Infectivity of severe acute respiratory syndrome coronavirus 2 in children compared with adults.
Journal: CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne
Published: March 30, 2021
Salivary testing of COVID-19: evaluation of serological testing following positive salivary results.
Salivary testing of COVID-19: evaluation of serological testing following positive salivary results.
Journal: BMC infectious diseases
Published: March 03, 2021
Simulated sunlight decreases the viability of SARS-CoV-2 in mucus.
Journal: PloS one
Published: January 13, 2021
Last Updated: 09/26/2026